NCT05696977View on ClinicalTrials.gov

Effect of Obesity on Cyclosporine Blood Trough Level in Nephrotic Syndrome Patients

PHASE4RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 17, 2022

Primary Completion Date

February 29, 2024

Study Completion Date

April 30, 2024

Conditions

Nephrotic Syndrome

Interventions

DRUG

Cyclosporine Capsule

Determination of the most appropriate weight based dose of Cyclosporine to achieve the target therapeutic drug level and response and its relation with fat percentage and lipid profile

Trial Locations (1)

Unknown

RECRUITING

Alexandria University, Alexandria

All Listed Sponsors

lead

Alexandria University

OTHER